Efficient recombinant of Lym-1 scFv gene using multiple doubly- restricted DNA fragments

Cancer Biotherapy and Radiopharmaceuticals

Volumn 14, Issue 2, 1999, Pages 139-143

  Shi, Xu Bao ^a   Gumerlock, Paul H ^a   Kroger, Linda ^a   DeNardo, Gerald L ^a   DeNardo, Sally J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Radiodiagnosis and Therapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; ENDODEOXYRIBONUCLEASE AVAI; ENDODEOXYRIBONUCLEASE DDEI; ENDODEOXYRIBONUCLEASE HHAI; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY LYM 1; MONOCLONAL ANTIBODY LYM-1; RECOMBINANT DNA; SYNTHETIC DNA; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXPRESSION VECTOR; GENE CONSTRUCT; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOTHERAPY; RESTRICTION FRAGMENT; RESTRICTION MAPPING; AGAR GEL ELECTROPHORESIS; GENETICS; IMMUNOGLOBULIN GENE; ISOLATION AND PURIFICATION; PROMOTER REGION; REGULATORY SEQUENCE; SYNTHESIS;

ANTIBODIES, MONOCLONAL; DEOXYRIBONUCLEASE ECORI; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA, RECOMBINANT; ELECTROPHORESIS, AGAR GEL; GENES, IMMUNOGLOBULIN; GENES, SYNTHETIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 0032586390     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1999.14.139     Document Type: Article

References (13)

1. DeNardo SJ, DeNardo GL, O'Grady LF, Macey DJ, Mills SL, Epstein AL, Peng J, McGahan JP. Treatment of a patient with B cell lymphoma by I-131 Lym-1 monoclonal antibodies. Int J Biol Markers 1987;2:49.
2. 131 I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma. J Clin Oncol 1998;16:3264.
3. 131I-LYM-1 Antibody. Cancer Biotherapy Radiopharmaceuticals 1998;13: 239.
4. DeNardo GL, Lewis JP, DeNardo SJ, O'Grady LF. Effect of Lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemia. Cancer 1994;73:1425.
5. DeNardo GL, Lambom KR, DeNardo SJ, Goldstein DS, Dolber-Smith EG, Kroger LA, Larkin EC, Shen S. Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies. Cancer Res 1995; 55:5893s.
6. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee S, Lee T, Pope SH, Riordan GS, Whitlow M. Single-chain antigen-binding proteins. Science 1988;242:423.
7. Thirion S, Motmans K, Heyligen H, Janssens J, Raus J, Vandevyver C. Mono-and bispecific single-chain antibody fragments for cancer therapy. Eur J Cancer Prevention 1996;5:507.
8. Bejcek BE, Wang D, Berven E, Pennell CA, Peiper SC, Poppema S, Uckun FM, Kersey JH. Development and characterization of three recombinant single chain antibody fragments (scFvs) directed against the CD19 antigen. Cancer Res 1995;55:2346.
9. Shi XB, Gumerlock PH, Wellman AA, Meares CF, DeNardo GL, Meyers FJ, DeNardo SJ. Rapid construction of a gene containing Lym-1 antibody variable regions. PCR methods and appl 1993;3:46.
10. Higuchi R. Using PCR to engineer DNA. In: "PCR Technology: Principles and applications for DNA amplification." Erlich HA. ed, M stockton press, 1989, pp 61-70.
11. Kipriyanov SM, Dubel S, Breitling F, Kontermann RE, Heymann S, Little M. Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines. Cell Biophysics 1995;26:187.
12. Navarro-Teulon I, Peraldi-Roux S, Bemardi T, Marin M, Piechaczyk M, Shire D, Pau B, Biard-Piechaczyk M. Expression in Escherichia coli of soluble and M13 phage-displayed forms of a single-chain antibody fragment specific for digoxin: assessment in a novel drug immunoassay. Immunotechnology 1995;1:41.
13. Brinkmann U, Pai LH, Fitzgerald DJ, Willingham M, Pastan I. B3(fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc Natl Acad Sci USA 1991; 88:8616.